Verlag: University Press of Mississippi, 1997
ISBN 10: 0878059105 ISBN 13: 9780878059102
Anbieter: Better World Books, Mishawaka, IN, USA
Zustand: Good. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.
Verlag: University Press of Mississippi, 1997
ISBN 10: 0878059113 ISBN 13: 9780878059119
Anbieter: Better World Books, Mishawaka, IN, USA
Erstausgabe
Zustand: Good. 1st Edition. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.
Verlag: University Press of Mississippi, 1997
ISBN 10: 0878059113 ISBN 13: 9780878059119
Anbieter: Better World Books, Mishawaka, IN, USA
Erstausgabe
Zustand: Very Good. 1st Edition. Former library book; may include library markings. Used book that is in excellent condition. May show signs of wear or have minor defects.
Verlag: Oxford University Press, 1998
ISBN 10: 1841100064 ISBN 13: 9781841100067
Anbieter: CorgiPack, Fulton, NY, USA
Hardcover. Zustand: VG. Text free of underlining, writing and highlighting. Alzheimer's disease (AD) is a progressively degenerative form of dementia in which impaired cognitive functioning is the earliest and most prominent clinical 'symptom'. While much has been learned about the disease process itself, progress in treatment has been slow and the search for new and more effective therapies is intensifying rapidly. This book critically assesses the impact of the next generation of drug treatments in AD. It will serve as a valuable reference source for clinical researchers involved in all aspects of drug development in AD including neurologists, psychiatrists, geriatricians, psychologists, psychopharmacologists, clinical pharmacologists and all those involved in the design and analysis of pharmaceutical trials. ' 208 pages.
Verlag: University Press of Mississippi, 1997
ISBN 10: 0878059105 ISBN 13: 9780878059102
Anbieter: Better World Books Ltd, Dunfermline, Vereinigtes Königreich
Zustand: Good. Ships from the UK. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.
Verlag: Wiley, 1994
ISBN 10: 0471951455 ISBN 13: 9780471951452
Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
Hardcover. Zustand: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 0.9.
Verlag: Wiley, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 2.
Verlag: Wiley, 1994
ISBN 10: 0471951455 ISBN 13: 9780471951452
Anbieter: Bookmans, Tucson, AZ, USA
Hardcover. Zustand: Good. Satisfaction 100% guaranteed.
Verlag: Wiley, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: Phatpocket Limited, Waltham Abbey, HERTS, Vereinigtes Königreich
Zustand: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. May contain underlining and/or highlighting. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Verlag: John Wiley & Sons Ltd, Bognor Regis, United Kingdom, 1996
ISBN 10: 0471957135 ISBN 13: 9780471957133
Anbieter: PsychoBabel & Skoob Books, Didcot, Vereinigtes Königreich
hardcover. Zustand: Very Good. Zustand des Schutzumschlags: No Dust Jacket. In the exciting and rapidly expanding field of drug development, there is an emphasis on the clear delineation of psychiatric symptoms, syndromes and disorders, and disorders, and improved strategies for making diagnoses. Here the authors concentrate on the anxiolytics, a group of drugs which must be evaluated in carefully defined groups of patients using sensitive outcome measures. Efficacy is not always easy to establish and large clinical trials are needed to verify effectiveness of the drug, the degree of efficacy and the risks of unwanted effects. Conducting these trials is not an easy matter and this timely, critical and comprehensive guide aims to provide awareness of the major issues surrounding development of anxiolytics and, in particular, details of the techniques needed to assess new and hopefully improved therapies. This book, written by authors well known for their extensive experience in the field of drug development, will be of interest to the academic community frequently involved in clinical trials of potential anxiolytic compounds, as well as to the pharmaceutical industry in the formulation of drug development programmes for new anxiolytics. Clean Copy.
Verlag: Wileyâ"Blackwell, 1994
ISBN 10: 0471951455 ISBN 13: 9780471951452
Anbieter: BookstoYou, Hay-on-Wye, HEREF, Vereinigtes Königreich
hardcover. Zustand: New.
Verlag: John Wiley & Sons, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: NEPO UG, Rüsselsheim am Main, Deutschland
Gebundene Ausgabe. Zustand: Sehr gut. 491 Seiten ex Library Book / aus einer wissenschafltichen Bibliothek / Sprache: Englisch Gewicht in Gramm: 969.
Verlag: john wiley & sons chichester 1996, 1996
Anbieter: Hard to Find Books NZ (Internet) Ltd., Dunedin, OTAGO, Neuseeland
Verbandsmitglied: IOBA
Erstausgabe
first edition 163pp NF (purple dec. paper boards, v. sl rubbed) a very nice example, attractively presented.
Verlag: John Wiley & Sons Inc, 1998
ISBN 10: 0471981281 ISBN 13: 9780471981282
Anbieter: GoldenWavesOfBooks, Fayetteville, TX, USA
Hardcover. Zustand: new. New. Fast Shipping and good customer service.
Verlag: Wiley, 1996
ISBN 10: 0471957135 ISBN 13: 9780471957133
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
Hardcover. Zustand: Like New. Like New. book.
Verlag: Wiley, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: HPB-Red, Dallas, TX, USA
hardcover. Zustand: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!.
Verlag: John Wiley & Sons, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Verlag: Wiley, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In.
Verlag: Wiley, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: Brook Bookstore, Milano, MI, Italien
Zustand: new.
Verlag: John Wiley & Sons Inc, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 491 pages. 9.75x6.50x1.50 inches. In Stock.
Verlag: John Wiley and Sons Ltd, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Erstausgabe
Zustand: New. Spanning many of the major drug classes, this guide explores the key factors of drug development, concentrating on general methodology and regulatory issues. It considers the pharmacology of major receptor types and the pharmacodynamics of a wide range of therapeutic drug classes. Editor(s): Cutler, Neal R.; etc.; Sramek, John J. (California Clinical Trials Medical Group, Beverly Hills, California, USA); Narang, P.K. Num Pages: 508 pages, black & white illustrations. BIC Classification: MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 245 x 163 x 35. Weight in Grams: 914. . 1994. 1st Edition. Hardcover. . . . .
Verlag: John Wiley & Sons, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: moluna, Greven, Deutschland
Zustand: New. Spanning many of the major drug classes, this guide explores the key factors of drug development, concentrating on general methodology and regulatory issues. It considers the pharmacology of major receptor types and the pharmacodynamics of a wide range of t.
Verlag: John Wiley and Sons Ltd, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. Spanning many of the major drug classes, this guide explores the key factors of drug development, concentrating on general methodology and regulatory issues. It considers the pharmacology of major receptor types and the pharmacodynamics of a wide range of therapeutic drug classes. Editor(s): Cutler, Neal R.; etc.; Sramek, John J. (California Clinical Trials Medical Group, Beverly Hills, California, USA); Narang, P.K. Num Pages: 508 pages, black & white illustrations. BIC Classification: MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 245 x 163 x 35. Weight in Grams: 914. . 1994. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Verlag: Wiley Sep 1994, 1994
ISBN 10: 0471950521 ISBN 13: 9780471950523
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - In recent years it has become clear that early information about pharmacodynamics leads to more efficient trial designs and improved clinical guidelines for the use of all drugs. Spanning many of the major drug classes, this book offers the essential facts and concepts and includes an authoritative section on general methodology and regulatory issues. The molecular biology and pharmacology of major receptor types are considered, as is the detailed pharmacodynamics of a wide range of therapeutic drug classes. The book will be of interest to researchers, clinical pharmacologists, physicians and regulators working in academia as well as the pharmaceutical industry worldwide.